|
Market Closed -
Nasdaq
16:00:00 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 114.40 USD | +5.19% |
|
+1.62% | -34.27% |
| 11-02 | Mizuho Adjusts Price Target on Insmed to $158 From $154, Keeps Outperform Rating | MT |
| 10-29 | Insmed Q3 Net Loss Narrows; Revenue Rises | MT |
| Market Cap | 25.1B 22.51B 20.57B 18.78B 35.38B 2,359B 36.5B 248B 98.88B 1,259B 94.21B 92.19B 3,974B | P/E 2026 * |
-69.1x | P/E 2027 * | 158x |
|---|---|---|---|---|---|
| Enterprise Value | 24.58B 22.05B 20.15B 18.39B 34.66B 2,311B 35.75B 243B 96.85B 1,233B 92.28B 90.3B 3,893B | EV / Sales 2026 * |
13.2x | EV / Sales 2027 * | 8.07x |
| Free-Float |
99.49% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| INSM | Delayed | |
CBOE
| INSM | Real-time | |
|
Tradegate
| IM8N | Real-time | |
|
Mexican S.E.
| INSM * | End-of-day quote | |
|
Boerse Muenchen
| IM8N | Real-time | |
|
Berne S.E.
| IM8N | End-of-day quote | |
|
Deutsche Boerse AG
| IM8N | Delayed | |
|
Börse Stuttgart
| IM8N | Delayed | |
|
Borsa Italiana
| 1INSM | End-of-day quote | |
|
Xetra
| IM8N | Delayed |
Last Transcript: Insmed Incorporated
| 1 day | +5.19% | ||
| 1 week | +1.62% | ||
| Current month | +1.62% | ||
| 1 month | +12.45% | ||
| 3 months | -12.73% | ||
| 6 months | +8.96% | ||
| Current year | -34.27% |
| 1 week | 102.69 |  | 114.65 |
| 1 month | 92.62 | | 116.37 |
| Current year | 90.39 | | 186.19 |
| 1 year | 90.39 | | 212.75 |
| 3 years | 21.92 | | 212.75 |
| 5 years | 16.04 | | 212.75 |
| 10 years | 11.31 | | 212.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Will Lewis
CEO | Chief Executive Officer | 57 | 2012-09-09 |
Martina Flammer
CTO | Chief Tech/Sci/R&D Officer | 62 | 2019-12-18 |
Roger Adsett
COO | Chief Operating Officer | 57 | 2019-11-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Melvin Sharoky
CHM | Chairman | 75 | 2009-06-15 |
Will Lewis
CHM | Chairman | 57 | 2018-11-07 |
David Brennan
BRD | Director/Board Member | 72 | 2014-05-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/9/26 | Sell | Director | -25,000 | 0.0114% | ||
| 8/17/26 | Sell | Director | -5,000 | 0.0023% | ||
| 8/10/26 | Exercice | Chief Operating Officer | 719,550 | 0.3320% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.19% | +1.62% | -39.69% | +368.87% | 25.1B | |
| -4.83% | +3.51% | +55.00% | +63.79% | 66.7B | |
| +0.02% | +1.07% | +11.72% | +75.63% | 56.88B | |
| -1.34% | +2.98% | +25.08% | +100.18% | 56.53B | |
| +5.09% | +9.89% | +27.19% | +105.85% | 46.49B | |
| +2.62% | +1.68% | +29.16% | +35.86% | 44.8B | |
| +8.24% | +0.51% | +215.16% | +794.74% | 41.59B | |
| -1.86% | +10.13% | +28.14% | +55.48% | 35.35B | |
| -2.97% | -9.84% | +90.91% | +73.49% | 33.29B | |
| -2.18% | +7.06% | +40.97% | -3.11% | 24.92B | |
| Average | +0.80% | +3.09% | +48.36% | +167.08% | 43.16B | |
| Weighted average by Cap. | +0.49% | +3.30% | +49.39% | +156.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.86B 1.67B 1.53B 1.39B 2.62B 175B 2.71B 18.39B 7.33B 93.36B 6.99B 6.84B 295B | 2.99B 2.68B 2.45B 2.24B 4.22B 281B 4.35B 29.57B 11.79B 150B 11.23B 10.99B 474B |
| Net income | -357M -321M -293M -267M -504M -33.59B -520M -3.53B -1.41B -17.92B -1.34B -1.31B -56.58B | 167M 150M 137M 125M 236M 15.74B 243M 1.65B 660M 8.4B 628M 615M 26.51B |
| Net Debt | -514M -461M -422M -385M -725M -48.36B -748M -5.08B -2.03B -25.8B -1.93B -1.89B -81.46B | -949M -851M -778M -710M -1.34B -89.21B -1.38B -9.38B -3.74B -47.6B -3.56B -3.49B -150B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-06 | US$114.41 | +5.19% | 3,379,993 |
| 26-11-05 | US$108.76 | -1.13% | 2,616,308 |
| 26-11-04 | US$110.00 | +5.32% | 4,944,543 |
| 26-11-03 | US$104.44 | -4.46% | 6,216,187 |
| 26-11-02 | US$109.31 | -2.90% | 4,241,735 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INSM Stock
Select your edition
All financial news and data tailored to specific country editions
